12:00 AM
 | 
Nov 15, 1999
 |  BC Week In Review  |  Company News  |  Deals

Endo Pharmaceuticals Inc., Lavipharm Laboratories Inc. deal

Endo acquired exclusive worldwide rights to Lavipharm’s Quick-Dis and transdermal drug delivery technologies for use in pain management. The companies will...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >